The purpose of this study is to evaluate the effect of increased stomach pH on how much
evacetrapib is found in the blood stream and how long the body takes to get rid of it when
given to healthy participants. Information about any side effects that may occur will also
There are two parts to the study. Participation in both parts will be required.
The study will last approximately 30 days, not including screening.
- Overtly healthy participants, as determined by medical history and physical
- Females must be of non-child-bearing potential
- Have a body mass index of 18 to 32 kilograms per square meter (kg/m^2)
- Have known allergies to evacetrapib, omeprazole, related compounds, or any components
of the evacetrapib or omeprazole formulations